ClinicalTrials.gg
Sign In

Dana-Farber Cancer Institute clinical trials

Listed in the registry as: University, hospital or other organization.

The registry lists 832 studies whose lead sponsor is Dana-Farber Cancer Institute. 120 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.

Keep track of what changes. Save the Dana-Farber Cancer Institute studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
470
Active, not recruiting
113
Recruiting
104
Terminated
89
Withdrawn
31
Not yet recruiting
14

Phase

Phase 2
381
Phase 1
184
Phase 3
17
Early Phase 1
12
Phase 4
2

Where

United States
809
Canada
9
Rwanda
2
Iran, Islamic Republic of
1
Puerto Rico
1
Germany
1

Focus areas

Conditions Dana-Farber Cancer Institute leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Breast Neoplasms134Prostatic Neoplasms57Leukemia45Neoplasms42Multiple Myeloma30Lung Neoplasms29Lymphoma27Carcinoma26Ovarian Neoplasms26Waldenstrom Macroglobulinemia26Head and Neck Neoplasms25Myelodysplastic Syndromes24Melanoma23Graft vs Host Disease22Leukemia, Lymphocytic, Chronic, B-Cell21Precursor Cell Lymphoblastic Leukemia-Lymphoma21Leukemia, Myeloid, Acute20Pancreatic Neoplasms20Sarcoma18Carcinoma, Non-Small-Cell Lung17Hematologic Neoplasms16Leukemia, Myeloid16Squamous Cell Carcinoma of Head and Neck16Fallopian Tube Neoplasms15
Show all 40 areas
Carcinoma, Squamous Cell14Colorectal Neoplasms14Glioblastoma14Brain Neoplasms13Endometrial Neoplasms13Hodgkin Disease13Neoplasm Metastasis13Gastrointestinal Neoplasms12Central Nervous System Neoplasms11Esophageal Neoplasms11Adenocarcinoma10Bronchiolitis Obliterans Syndrome10Carcinoma, Ovarian Epithelial10Glioma10Smoldering Multiple Myeloma10Stomach Neoplasms10

Studies

Recruiting first, then most recently updated. Showing 50 of 832. Browse all 832 →